cro.directory
← Compare landing

Axcelead Drug Discovery Partners, Inc. vs BioDuro-Sundia

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/axcelead/bioduro-sundia

CategoryAxcelead Drug Discovery Partners, Inc.BioDuro-Sundia
Listed sitecrocro
SummaryAxcelead provides integrated drug discovery research services across small molecules, nucleic acids, antibodies, and peptides, with specialized expertise in oncology, immunology, and neurology. Founded in 2017 from Takeda's research base, the company serves pharmaceutical companies, bioventures, and academia with above-industry screening hit rates and project success metrics.BioDuro-Sundia is a contract research, development, and manufacturing organization (CRDMO) with 30 years of expertise providing integrated drug discovery, development, and manufacturing services from target identification through IND submission.
Services
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Genetic Toxicology
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Preclinical In Vitro Studies
  • Specialized & Large-Animal Models
  • GLP Toxicology
  • Biomarker Assays
  • Flow Cytometry Services
  • Bioanalysis
  • Bioinformatics & Data Science
  • Genomics & Sequencing Services
  • Proteomics Services
  • Pathology & Histology Services
  • Translational Research
  • Oncology Specialty Services
  • Immunology & Inflammation Services
  • CNS Specialty Services
  • Cardiovascular & Metabolic Specialty Services
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • Computational & In-Silico Drug Discovery
  • Medicinal Chemistry
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Genetic Toxicology
  • Preclinical In Vitro Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Specialized & Large-Animal Models
  • Preclinical In Vivo Studies
  • Bioanalysis
  • Biomarker Assays
  • Flow Cytometry Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Translational Research
  • US FDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Regulatory Affairs
  • Immunogenicity Assays (ADA / NAb)
  • Oncology Specialty Services
  • Immunology & Inflammation Services
Modalities
  • Small Molecule
  • Oligonucleotide
  • Antibody-Drug Conjugate (ADC)
  • Biologics (Monoclonal Antibodies)
  • Peptide
  • mRNA
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Peptide
Indications
  • Oncology
  • Immunology
  • Neurology
  • Nephrology
  • Metabolic
  • Cardiovascular
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Respiratory
LocationsData not yet provided.
  • Headquarters, Irvine, California, United States
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.